TTR stabilizers: halts disease progression PO tablets(1) FDA approved(2) Off-label, NSAID: contraindicated for renal failure and thrombocytopenia; used cautiously with anticoagulation and gastrointestinal bleed. The gene discussed is TTR; the disease is Renal insufficiency.